Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Zlatohlávek

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Vnitrni Lekarstvi|November 4, 2004
[Serum lipids in drug addicts]H Wilczek, R Ceska, L Zlatohlávek
Vnitrni Lekarstvi|June 21, 2007
[Lipoprotein (a)]L Zlatohlávek, K Zídková, M Vrablík
Casopis Lekaru Ceskych|September 19, 2007
[Genetic aspects of high variability of lipoprotein(a) levels]K Zídková, L Zlatohlávek, R Ceska
Physiological Research|October 28, 2009
Omega-3 fatty acids and cardiovascular disease risk: do we understand the relationship?M Vrablík, M Prusíková, M Šnejdrlová, et al.
Vnitrni Lekarstvi|September 18, 2010
[Comprehensive management of cardiovascular risk. Focusing on telmisartan]R Ceska, S Krutská, L Zlatohlávek, et al.
Physiological Research|August 27, 2014
Biomarkers of cardiometabolic risk in obese/overweight children: effect of lifestyle interventionM Vrablík, M Dobiášová, L Zlatohlávek, et al.
Vnitrni Lekarstvi|September 17, 2010
[Hyperlipoproteinaemia and dyslipoproteinaemia II. Therapy: non-pharmacological and pharmacological approaches]R Ceska, S Krutská, L Kasná, et al.
Physiological Research|January 18, 2008
Lipoprotein(a) and its position among other risk factors of atherosclerosisL Zlatohlávek, K Zídková, M Vrablík, et al.
Vnitrni Lekarstvi|April 9, 2008
[Statin pharmacokinetics]J A Hubácek, V Adámková, K Zídková, et al.
Physiological Research|July 19, 2016
Statin-induced changes in mitochondrial respiration in blood platelets in rats and human with dyslipidemiaJ Vevera, Z Fišar, T Nekovářová, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Vnitrni Lekarstvi|November 4, 2004
[Serum lipids in drug addicts]H Wilczek, R Ceska, L Zlatohlávek
Vnitrni Lekarstvi|June 21, 2007
[Lipoprotein (a)]L Zlatohlávek, K Zídková, M Vrablík
Casopis Lekaru Ceskych|September 19, 2007
[Genetic aspects of high variability of lipoprotein(a) levels]K Zídková, L Zlatohlávek, R Ceska
Physiological Research|October 28, 2009
Omega-3 fatty acids and cardiovascular disease risk: do we understand the relationship?M Vrablík, M Prusíková, M Šnejdrlová, et al.
Vnitrni Lekarstvi|September 18, 2010
[Comprehensive management of cardiovascular risk. Focusing on telmisartan]R Ceska, S Krutská, L Zlatohlávek, et al.
Physiological Research|August 27, 2014
Biomarkers of cardiometabolic risk in obese/overweight children: effect of lifestyle interventionM Vrablík, M Dobiášová, L Zlatohlávek, et al.
Vnitrni Lekarstvi|September 17, 2010
[Hyperlipoproteinaemia and dyslipoproteinaemia II. Therapy: non-pharmacological and pharmacological approaches]R Ceska, S Krutská, L Kasná, et al.
Physiological Research|January 18, 2008
Lipoprotein(a) and its position among other risk factors of atherosclerosisL Zlatohlávek, K Zídková, M Vrablík, et al.
Vnitrni Lekarstvi|April 9, 2008
[Statin pharmacokinetics]J A Hubácek, V Adámková, K Zídková, et al.
Physiological Research|July 19, 2016
Statin-induced changes in mitochondrial respiration in blood platelets in rats and human with dyslipidemiaJ Vevera, Z Fišar, T Nekovářová, et al.
Pageof 2